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Abstract
The interplay of specific leukocyte subpopulations, resident cells and proalgesic mediators results in pain in inflammation.
Proalgesic mediators like reactive oxygen species (ROS) and downstream products elicit pain by stimulation of transient
receptor potential (TRP) channels. The contribution of leukocyte subpopulations however is less clear. Local injection of
neutrophilic chemokines elicits neutrophil recruitment but no hyperalgesia in rats. In meta-analyses the monocytic
chemoattractant, CCL2 (monocyte chemoattractant protein-1; MCP-1), was identified as an important factor in the
pathophysiology of human and animal pain. In this study, intraplantar injection of CCL2 elicited thermal and mechanical
pain in Wistar but not in Dark Agouti (DA) rats, which lack p47phox, a part of the NADPH oxidase complex. Inflammatory
hyperalgesia after complete Freund’s adjuvant (CFA) as well as capsaicin-induced hyperalgesia and capsaicin-induced
current flow in dorsal root ganglion neurons in DA were comparable to Wistar rats. Macrophages from DA expressed lower
levels of CCR2 and thereby migrated less towards CCL2 and formed limited amounts of ROS in vitro and 4-hydroxynonenal
(4-HNE) in the tissue in response to CCL2 compared to Wistar rats. Local adoptive transfer of peritoneal macrophages from
Wistar but not from DA rats reconstituted CCL2-triggered hyperalgesia in leukocyte-depleted DA and Wistar rats. A
pharmacological stimulator of ROS production (phytol) restored CCL2-induced hyperalgesia in vivo in DA rats. In Wistar rats,
CCL2-induced hyperalgesia was completely blocked by superoxide dismutase (SOD), catalase or tempol. Likewise, inhibition
of NADPH oxidase by apocynin reduced CCL2-elicited hyperalgesia but not CFA-induced inflammatory hyperalgesia. In
summary, we provide a link between CCL2, CCR2 expression on macrophages, NADPH oxidase, ROS and the development
CCL2-triggered hyperalgesia, which is different from CFA-induced hyperalgesia. The study further supports the impact of
CCL2 and ROS as potential targets in pain therapy.
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Introduction
In inflammation leukocyte subpopulations may play different
roles in the generation of hyperalgesia. Intraplantar injection of
the neutrophilic chemokine CXCL2/3 (macrophage inflammato-
ry protein, MIP-2) leads to a selective accumulation of neutrophils.
However, in contrast to complete Freund’s adjuvant induced
(CFA) inflammation with similar numbers of neutrophils in the
tissue, CXCL2/3 induces no mechanical or thermal hyperalgesia
[1]. In the early phase of CFA inflammation, neutrophils tonically
release opioid peptides resulting in basal analgesia, which could
counterbalance proalgesic effects [2]. Therefore, other cell
populations appear to be responsible for inflammatory hyperalge-
sia. Monocytes and macrophages are major contributors to
inflammatory infiltrate in later phases of inflammation [3].
CCL2 is an important and well-characterized monocytic
chemokine [4,5,6]. CCL2 is a critical player in neuropathic pain
and might be important to inflammatory pain [6,7]. Injection of
CCL2 in the paw elicits thermal and mechanical hyperalgesia [8].
Furthermore, exposure of macrophages to CCL2 results in the
release of reactive oxygen species (ROS), proinflammatory
cytokines (e.g. IL-1, TNF-a, MCP-1) and profibrotic growth
factors (e.g. PDGF, TGF-b) [9,10]. The phagocyte NADPH
oxidase complex generates ROS. ROS play a role in the
pathogenesis of acute and chronic pain and have been postulated
as mediators of inflammatory [11] and neuropathic pain e.g.
chemotherapy-induced neuropathic pain [12]. ROS-induced
oxidative stress during inflammation results in highly reactive
lipid peroxidation products like 4-hydroxynonenal (4-HNE)
protein adducts [13]. Potential targets of ROS are transient
receptor potential vannilloid 1 (TRPV1) or transient receptor
potential ankyrin 1 (TRPA1) expressed on nociceptors.
ROS production by the phagocyte NADPH oxidase complex is
achieved by two catalytic domains including gp91phox and p22phox
a regulatory domain containing p40phox, p67phox and p47phox,
coded by ncf1. NADPH oxidase can be inhibited by apocynin [14].
The NOX2 complex (the phagocyte NADPH oxidase) yields
superoxide anion, which is further transformed into hydrogen
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peroxide and hydroxyl radicals [15]. Superoxide dismutase (SOD)
catalyses the transformation of superoxide into oxygen and
hydrogen peroxide. Catalase catalyses the decomposition of
hydrogen peroxide to water and oxygen [16]. Thus, they are an
important antioxidant defense in nearly all cells exposed to ROS.
Dark Agouti (DA) rats develop an increased susceptibility to
arthritis due to a genetic polymorphism for ncf1 encoding p47phox
[17]. This variant of ncf1 results in a reduced release of ROS from
all leukocyte populations including peritoneal macrophages [18].
As a consequence macrophages are not able to suppress the T-cell
response, which in turn leads to an increased arthritis [17]. In
comparison, Wistar rats are less susceptible to adjuvant-induced
arthritis [19].
The present study examines the question whether the formation
of ROS from monocytes is important for the development of
CCL2-induced hyperalgesia. We compared DA rats with reduced
activity of NADPH oxidase to Wistar rats with normal NADPH
oxidase. Specifically we investigated 1) the contribution of
macrophages and ROS to CCL2-induced hyperalgesia using
cross over adoptive transfer experiments in DA and Wistar rats 2)
inflammatory pain and TRPV1 responsiveness in both strains 3)
CCR2 expression, leukocyte migration and ROS and HNE
generation in response to CCL2 in both strains and 4) specific role
of ROS and NADPH oxidase in CCL2-induced hyperalgesia in
Wistar rats.
Materials and Methods
Animals
Animal protocols were approved by the animal care committees
(Landesamt fu¨r Arbeitsschutz, Gesundheitsschutz und Technische
Sicherheit, Senate of Berlin and Regierung Unterfranken, both
Germany), and are in accordance with the International
Association for the Study of Pain [20]. Male Wistar and DA rats
weighing 180–220 g were treated as described below under brief
isoflurane anesthesia. Animals were sacrificed using intracardial
injection of a solution of T61 (embutramide, mebezonium and
tetracaine) under isoflurane anesthesia according to national
guidelines.
Measurement of nociceptive thresholds
Mechanical thresholds were determined using the paw pressure
algesiometer (modified Randall-Selitto test; Ugo Basile, Comerio,
Italy) as described before [1]. The pressure required to elicit paw
withdrawal using a blunt piston onto the dorsal surface of the hind
paw, the paw pressure threshold was determined. Treatments were
randomized, and the experimenter was blinded to the treatments.
A decrease in the paw pressure threshold was interpreted as pain
(hyperalgesia) whereas a rise in the paw pressure threshold was
interpreted as analgesia (antinociception).
Thermal nociceptive thresholds were measured by the Har-
greaves test as previously described [1]. The latency (time; s)
required to elicit paw withdrawal was measured with an electronic
timer (IITC Inc/Life Science, Woodland Hills, CA; USA) after
application of radiant heat to the plantar surface of a hind paw
from underneath the glass floor with a high-intensity light bulb.
The stimulus intensity was adjusted to 12 or 20 s for the paw
withdrawal latency (PWL) in noninflamed paws, and a cutoff of
30 s was set to avoid tissue damage. Different baseline latencies as
previously described in the literature [21] were used due to
requirements of the local animal welfare authorities. The average
of two measurements taken with 20 s intervals was calculated. A
decrease in paw withdrawal latency was interpreted as pain
(hyperalgesia) whereas a rise in paw withdrawal latency was
interpreted as analgesia (antinociception). To better compare data
with different baselines data are shown in %MPE (%MPE =
[PWLtreated2PWLpretreated]/[cutoff2PW pretreated])
DA and Wistar rats were i.pl. injected into the right hind paws
with several doses of CCL2 (0.3–3 mg in 100 ml) (Peprotech,
Hamburg, Germany) and mechanical as well as thermal pain
thresholds were measured after different time points (1–24 h).
Doses were chosen according to former studies and pilot
experiments [22,23]. Likewise, 150 ml complete Freund’s adjuvant
(CFA, Calbiochem, Darmstadt, Germany) was injected i.pl. to
measure thermal and mechanical pain thresholds after 2–48 h. In
DA rats, thermal pain thresholds were measured 15–120 min after
i.pl. injection of capsaicin (Sigma Aldrich) (30 mg in 100 ml 1%
EtOH) [24]. In the next set of experiments, Wistar rats were
treated with different doses of antioxidants like SOD (3–300 U
i.pl.), catalase (2–500 U i.pl.), tempol (1.5–15 mg i.p.) or apocynin
(1 mg i.pl.) (all Sigma Aldrich, Heidelberg, Germany) coinjected or
given 15 min before 3 mg CCL2 i.pl. Doses were chosen according
to the literature [11,14,16]. Mechanical pain thresholds were
measured after 0, 1 or 3 h.
Immunodepletion and adoptive transfer
Recipient rats were treated with cyclophosphamide (Baxter,
Unterschleissheim, Germany) according to a protocol established
in our laboratory [25]. Briefly, the animals were injected
intraperitonially (i.p.) three days and one day before the
experiment with 100 mg/kg and 50 mg/kg of cyclophosphamide,
respectively. This treatment results in over 90% reduction in
circulating leukocytes. For adoptive transfer different numbers of
macrophages from peritoneal macrophages from Wistar or DA
rats (see below) were injected intraplantarly (i.pl.) 30 min prior to
i.pl. injection of 3 mg CCL2 each in 50 ml solvent (0.9% NaCl) as
described before for adoptive transfer of neutrophils [23].
Phytol treatment of rats
To reconstitute ROS formation DA rats were injected
subcutaneously (s.c.) with 200 ml 3,7,11,15-Tetramethyl-2-hexan-
decen-1-ol (phytol, Sigma Aldrich, Heidelberg, Germany) 5 d
prior to i.pl. injection of CCL2 (0.3–3 mg in 100 ml) [26].
Monocytes/macrophages isolation from rats
Peritoneal monocytes/macrophages were harvested 4 d after
i.p. injection of 3 % thioglycollate in phosphate buffered saline [1].
Rats were sacrificed and the peritoneum lavaged with PBS/EDTA
(all Sigma Aldrich). Monocytes/macrophages were.95 % pure as
confirmed by flow cytometry.
Real-time reverse transcription-polymerase chain
reaction (RT-PCR) for CCR2 mRNA
Total RNA from peritoneal macrophages from DA and Wistar
rats was extracted using a commercially available kit (NucleoSpin
RNA II, Macherey-Nagel, Dueren, Germany). RNA from
macrophages was reversely transcribed into cDNA using the
High-Capacity cDNA Reverse Transcription Kit (Applied Biosys-
tems/Life Technologies, Carlsbad, CA, USA). cDNA from
peritoneal macrophages was amplified with TaqMan Gene
Expression Assay for CCR2 and GAPDH (Rn00573193_s1, Rn
0177576_g1, Applied Biosystems). The cycling conditions were: 50
cycles, annealing and elongation 1 min at 60uC. Mean Ct value of
all samples was 26.8 for CCR2 mRNA and 22.8 for GAPDH
mRNA. Results were calculated using the 2-ddCT method for
relative quantification.
Monocytes and Reactive Oxygen Species in Pain
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Chemotaxis assay
CCL2 dissolved in sterile Hanks balanced salt solution/0.5%
bovine serum albumin (Sigma Aldrich) was placed in the lower
well of a Boyden chamber (Costar, Amsterdam, Netherlands) and
26106 rat peritoneal macrophages from DA and Wistar rats in
the upper well. After 2 h incubation at 37uC and 5% CO2 the
number of cells in the cell suspension from the lower well was
quantified by flow cytometry using fluorescent beads (see below).
The migration index was calculated by dividing the number of
cells migrating towards CCL2 by the number of migrating cells
using Hanks balanced salt solution/bovine serum albumin alone
[27,28].
Flow cytometry – leukocyte subpopulations
Cellular staining in the subcutaneous paw tissue was performed
as previously described [1]. The right hind paws of either Wistar
rats or DA rats were injected with 100 ml 0.9 % NaCl or 3 mg
CCL2 (each for 3 h) or with 150 ml CFA (for 2 h) as positive
control. Animals were sacrificed and paw tissues were prepared for
FACS analysis.
Briefly, after enzymatic digestion and permeabilization, single
cell suspensions were incubated with the following primary and
secondary antibodies (all antibodies by BD Biosciences, Heidel-
berg, Germany unless stated otherwise): mouse anti rat CD45
phycoerythrin (PE) Cy5 monoclonal antibody identifies all
hematopoetic cells, 4 mg/ml), mouse anti-rat ED1 fluorescein
(FITC, recognizing the CD68 antigen expressed on monocytes/
macrophages, 2 mg/ml, Serotec, Du¨sseldorf, Germany). Absolute
numbers of cells per paw in the stained cell suspensions were
calculated using fluorescent TruCOUNTH beads. The FACS
Scan acquired 20.000–70.000 FACS events. Data analysis used
CellQuest software (all BD Biosciences).
Cell quantification after cyclophosphamide (CTX) immune
depletion was analyzed in peripheral blood from donor rats
collected through heart puncture. 100 ml of blood were lysed using
2 ml FACS Lysing Solution (BD Bioscience) and suspended in
PBS. One the verge of measurements cell suspensions were mixed
with TruCOUNTH beads (BD Biosciences) and analyzed as
described before [27].
Formation of ROS in peritoneal macrophages
16106 macrophages were first stimulated with CCL2 in
different concentrations (2 mg/ml and 0.5 mg/ml) and then
incubated with dihydrorhodamine 123 (DHR 123, PhagoburstH
(Bursttest), Orpegen Pharma, Heidelberg, Germany) which
becomes fluorescent when oxidized. ROS formation was mea-
sured after 1 h. Phorbol 12-myristate 13-acetate (PMA) was used
as a positive control. Fluorescence was determined by flow
cytometry and the geometric mean was obtained.
Immunofluorescence
Rats were deeply anesthetized with isoflurane and perfused
transcardially with 0.1 mM PBS, pH 7.4, and with cold PBS
containing 4% paraformaldehyde pH 7,4 (fixative solution). The
subcutaneous tissue was dissected from hind paws, postfixed in
the fixative solution, cryoprotected in 15% sucrose solution at
4uC overnight, embedded in tissue-Tek compound (OCT, Miles
Inc., Elkhart, IN), and frozen. Seven-micrometer-thick sections
were prepared on cryostat and mounted on gelatin-coated slides.
For immunostaining, the tissue sections were incubated with a)
polyclonal rabbit anti-HNE (Biotrend, Cologne, Germany) in
combination with mouse monoclonal anti-ED1 (CD68, Serotec,
Oxford, Great Britain) overnight. The tissue sections were
washed with PBS and then incubated with the appropriate
secondary antibodies: Texas red conjugated goat anti-rabbit
antibody in combination with FITC conjugated donkey anti-
mouse antibody. Finally, the tissues were washed in PBS, stained
with 49,6 diamidino-2-phenylindole (DAPI) and mounted on
vectashield (Vector Laboratories, Burlingame, CA). To demon-
strate specificity of staining, the following controls were included:
omission of either the primary antibodies or the secondary
antibodies [29].
Enzyme-linked immunosorbent assay (ELISA)
4-HNE or HNE is a well-known by-product of lipid
peroxidation after the generation of ROS and is widely accepted
as a stable marker for oxidative stress. For measurement of HNE
subcutaneous paw tissue was obtained and minced in 20 mM
Tris buffer. After centrifugation supernatant was used for
quantification of total protein content in the paw tissue.
Extracted protein was diluted in lysis buffer and incubated with
bicinchoninic acid (BCA) protein assay reagent (Pierce) for
quantification on a plate reader (Tecan). HNE content of paw
tissue was measured by a commercially available kit (OxiSe-
lectTM HNE-His Adduct ELISA Kit, Cell Biolabs) according to
the manufacturer’s instruction. It measures HNE adducts to
proteins.
Electrophysiology
DRGs of the spinal segments L1-S1 from male adult Wistar and
DA rats (200–250 g) were dissected, digested with collagenase and
trypsin followed by a percoll purification. DRG neurons were
plated on poly-L-lysine coated coverslips and cultured at 37uC and
5% CO2.in D-MEM supplemented with 10% horse serum, 1%
penicillin-streptomycin and 0.5% L-glutamine. DRG neurons
were incubated for 4 h prior to recording. Whole-cell recordings
from DRG neurons were performed at room temperature [30].
Borosilicate glass pipettes (Science Products, Hofheim, Germany)
had a resistance of 3–6 MV. Data were generated with an EPC 9-
amplifier and HEKA-software (both HEKA, Lambrecht, Ger-
many) and saved on an Apple G4 (Apple, Cupertino, CA, USA).
Extracellular solution: NaCl 125 mM, KCl 5 mM, MgCl2 1 mM,
CaCl2 2 mM, D(+)-Glucose 10 mM, Hepes 25 mM, pH: 7.4.
Pipette solution: NaCl 5 mM, KCl 140 mM, MgCl2 2 mM,
CaCl2 0.0785 mM (free Ca
2+ 0.001 mM), Hepes 10 mM, ATP
2 mM, EGTA 0.08 mM (all Merck or Sigma Chemicals),
pH 7.24. Capsaicin (Sigma Chemicals) was diluted in extracellular
solution and applied in ascending concentrations (0.5–1 mM).
Membrane potential was clamped to 270 mV during current
recordings. Whole cell recordings were done after application of
capsaicin (0.5–1 mM).
Statistical analysis
Data are presented as raw values or % maximal possible effect
(%MPE) (mean 6 SEM). Data were tested for normality and for
equal variance. Normally distributed data were analyzed by t-test.
If aliquots of one sample were exposed to different conditions or
repeated measurements were taken, a Two Way repeated
measurement (RM) ANOVA was used. The post hoc comparisons
were performed by Student-Newman-Keuls. In case of not
normally distributed data the test was performed on ranks.
Differences were considered significant if p,0.05.
Monocytes and Reactive Oxygen Species in Pain
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Results
CCL2-induced hyperalgesia in Wistar but not DA rats
Injection of CCL2 into the hind paw of Wistar rats elicited a
dose-dependent mechanical (Fig. 1A) and thermal (Fig. 1C)
hyperalgesia between 1 and 12 h returning to baseline at 24 h.
The maximal effect was seen at 3 h using 3 mg CCL2. This dose
and time point was used for further experiments. In contrast,
mechanical (Fig. 1B) and thermal (Fig. 1D) nociceptive
thresholds were unchanged following CCL2 injection into
NAPDH oxidase-deficient DA rats.
Similar development of inflammatory hyperalgesia and
TRPV1 responsiveness in DA compared to Wistar rats
To test whether DA rats have a more generalized defect in
nociception in response to inflammatory or proalgesic mediators,
we determined nociceptive thresholds after an inflammatory
stimulus (CFA). In DA rats mechanical and thermal nociceptive
thresholds were lowered in after i.pl. CFA. The mechanical
thresholds in DA rats were similar after CFA treatment compared
to Wistar rats (Fig. 2A, B), while the decrease in thermal
nociceptive thresholds after i.pl. injection of CFA was less
pronounced in DA rats compared to Wistar rats (Fig. 2C, D).
Thermal hyperalgesia after CFA (Fig. 2C, D) was more intense
than after CCL2 (Fig. 1C, D) in both strains. In vitro treatment of
cultured DRG neurons from DA rats and Wistar rats with
capsaicin elicited comparable inward currents in whole cell
recordings. There was a small but not significant difference in
current amplitude (Fig. 2E). To test whether DA rats have a
defect in TRPV1 function in vivo DA rats were treated i.pl. with
capsaicin (Fig. 2F). Thermal thresholds after i.pl. capsaicin
treatment were similar compared to Wistar rats as shown before
[24]. In DA rats the threshold decreased from 10.0 +/2 0.6 s (BL)
to 4.7 +/2 0.8 s (15 min) and in Wistar rats from 10.4 +/2 0.3 s
(BL) to 4.9 +/2 0.2 s (15 min).
Reduced CCR2 expression and macrophage chemotaxis
in DA rats
Local injection of chemokines results in recruitment of
leukocytes. In order to explore the effectiveness of recruitment,
the number of leukocytes in the inflammatory infiltrate was
analyzed by flow cytometry. Intraplantar injection of CFA lead to
the recruitment of similar numbers of ED1+ CD45+ macrophages
into the paw of both DA and Wistar rats but CCL2 injection did
not induce any macrophage recruitment in DA rats (Fig. 3A, B).
To explore causes for the defect in recruitment, CCR2 expression
and function was measured in peritoneal thioglycollate-elicited
inflammatory macrophages. Macrophages from DA rats expressed
small but significantly lower levels of CCR2 mRNA compared to
Wistar rats (Fig. 3C). Thiogycollate-elicited peritoneal macro-
phage from Wistar rats migrated towards CCL2 in vitro with a
maximal effect at 10 nM CCL2. In contrast, macrophage from
Figure 1. CCL2-induced hyperalgesia in Wistar, but not in Dark Agouti (DA) rats. Mechanical (A, B) and thermal (C, D) nociceptive
thresholds were quantified before and after i.pl. injection of CCL2 (0.3 mg – open circle, 1 mg – filled triangle, 3 mg – open triangle) or 0.9 % NaCl
(solvent = control – filled circle) into Wistar (A, C) and DA (B, D) rats (*p,0.05 versus time point 0 h, Two Way RM ANOVA, Student-Newman-Keuls,
n = 6). Data are presented as means 6 SEM of raw values (A, B) or % maximal possible effects (MPE) (C, D).
doi:10.1371/journal.pone.0063564.g001
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DA rats migrated indeed but to a significantly lesser extent in
response to CCL2 in vitro (Fig. 3D).
Restoration of defective ROS production CCL2-induced
hyperalgesia in DA rats
To circumvent the migratory defect of macrophages from DA
rats we examined CCL2-induced hyperalgesia in leukocyte-
depleted and reconstituted Wistar and DA rats using local
injection of peritoneal macrophages from donor rats. CCL2-
induced hyperalgesia in Wistar rats was completely abrogated after
depletion of leukocyte cells by pretreatment with cyclophospha-
mide (CTX) (Fig. 4A). CTX treatment resulted in a significant
depletion of white blood cells upon CTX treatment on day 23
(100 mg/kg) and day 21 (50 mg/kg) before CCL2 treatment
(Fig. 4B). Total leukocytes were reduced by around 80% (176.0
+/2 23.9 vs. 41.3 +/2 4.96104 cells/ml). Monocytes were
depleted by ca. 70 % (48.8 +/2 10.7 vs. 15.4 +/2 1.06104 cells/
ml), neutrophils by ca. 75 % (45.2 +/2 0.3 vs. 16.6 +/2 2.46104
cells/ml) and lymphocytes by almost 90 % (81.9 +/2 17.9 vs. 9.1
+/2 1.56104 cells/ml). CCL2-induced hyperalgesia was recon-
stituted if macrophages from Wistar rats were injected into the
hind paw of leukocyte-depleted Wistar (Fig. 4C) or DA rats
(Fig. 4E). In contrast, adoptive transfer of macrophages from DA
rats into leukocyte-depleted Wistar (Fig. 4D) or DA rats (Fig. 4F)
did not induce changes in nociceptive thresholds after CCL2
Figure 2. Comparable nociceptive thresholds and DRG currents in Wistar and Dark Agouti (DA) rats. Rats received an i.pl. injection of
CFA (A–D; ipsilateral injected paw = open circle, contralateral, non injected paw = filled circle). Mechanical (A, B) and thermal nociceptive (C, D,)
thresholds were quantified (*p,0.05 versus time point 0 h, Two Way RM ANOVA, Student-Newman-Keuls, n = 6). Data are presented as means6 SEM
of raw values (A, B) or % maximal possible effects (MPE) (C, D). (E) DRG-neurons from naı¨ve DA rats were obtained and cultured for 48 h.
Representative traces of whole cell recordings are shown after application of capsaicin (500, 1000 nM, left). Bar graph quantifies capsaicin-activated
inward currents in DRG neurons from Wistar and DA rats (right) (n = 9, means 6 SEM, p.0.05, t- test). In addition DA rats received i.pl. injection of
capsaicin (F; solvent – filled circle, 30 mg capsaicin – open circle) and thermal nociceptive thresholds were quantified (*p,0.05 versus time point 0 h,
Two Way RM ANOVA, Student-Newman-Keuls, n = 6). Data are presented as means 6 SEM of % maximal possible effects (MPE).
doi:10.1371/journal.pone.0063564.g002
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injection. No effect was observed after CTX pretreatment and i.pl.
injection of cells or CTX pretreatment and i.pl. solvent (Fig. 4C).
To analyze whether CCL2 actually triggered ROS production,
oxidative burst was quantified by flow cytometry using DHR 123
oxidation. Macrophages from Wistar rats (Fig. 5A), but not DA
rats (Fig. 5B) significantly liberated ROS in response to CCL2
(Fig. 5C). HNE adducts are lipid peroxidation products and
formed downstream of ROS. Quantification of HNE using
ELISA and immunohistochemistry in Wistar rats demonstrated a
significantly higher HNE content in CCL2-injected paws
(Fig. 5D, E). HNE production was mainly seen in ED1+
macrophages. However not all ED1+ macrophages produced
HNE. No increase of HNE content was seen in DA rats treated
with CCL2. DA rats in general formed less HNE compared to
Wistar rats under baseline conditions. ROS production in DA
rats can be reconstituted by pretreatment with phytol [26].
Subcutaneous injection of phytol for 5 days prior resulted in a
dose-dependent increase in CCL2-induced hyperalgesia in DA
rats (Fig. 5F).
Inhibition of ROS production and scavenging its
byproducts in Wistar rats abolishes CCL2-induced
hyperalgesia
In the last step, we further evaluated the contribution of ROS
formation to CCL2-induced hyperalgesia. Coinjection of the
NADPH oxidase inhibitor, apocynin, blocked CCL2-induced
hyperalgesia (Fig. 6A). In contrast, treatment with apocynin in 4 d
CFA hind paw inflammation did not alter the hyperalgesia in these
animals (Fig. 6B). We next examined whether inhibition of ROS
scavenging enzymes blocks CCL2-induced hyperalgesia in Wistar
rats. SOD is an enzyme that catalyzes the conversion of
superoxide into oxygen and hydrogen peroxide. CCL2-induced
hyperalgesia was completely blocked if SOD was applied together
with CCL2 (Fig. 6C). Similar effects were observed with catalase,
an enzyme that catalyses the decomposition of hydrogen peroxide
to water and oxygen (Fig. 6D), and with the SOD mimetic
tempol, which acts as a membrane permeable superoxide
scavenger (Fig. 6E).
Figure 3. Defective CCL2-induced chemotaxis of macrophages from Dark Agouti (DA) in comparison to Wistar rats. Wistar (A) and DA
(B) rats were i.pl. injected with 3 mg CCL2 (light grey bars), with CFA (dark grey bars, positive control) or with 0.9% NaCl (black bars, solvent negative
control). Single cell suspensions were prepared from paw tissue and the number of infiltrating ED1+ CD45+ macrophages was quantified by flow
cytometry (n = 4, *p,0.05, One Way ANOVA, Student-Newman-Keuls). (C) CCR2 mRNA from peritoneal rat macrophages from Wistar (white bars) as
well as DA (black bars) rats was measured with real time PCR (*p,0.05, t-test, n = 6). (D) The migratory capacity of macrophages from Wistar rats
(white bars, n = 8) and DA rats (black bars, n = 5) was quantified in a Boyden chamber in response to CCL2 and solvent control (p,0.05, One way
ANOVA, Dunns-Method).
doi:10.1371/journal.pone.0063564.g003
Monocytes and Reactive Oxygen Species in Pain
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Discussion
In the present study, the chemokine CCL2 evoked leukocyte
recruitment and hyperalgesia via ROS generation in Wistar rats.
In contrast, DA rats with defective NAPDH oxidase activity did
not develop CCL2-induced hyperalgesia, but developed hyperal-
gesia in response to CFA and capsaicin. Adoptive transfer of
peritoneal macrophages from Wistar but not from DA rats
reconstituted CCL2-induced hyperalgesia in leukocyte-depleted
rats from both strains. CCR2 expression as well as in vitro
migration and CCL2-triggered ROS formation was reduced in
peritoneal macrophages in DA rats compared to Wistar.
Pharmacological stimulation of ROS production (phytol) made
CCL2-induced hyperalgesia possible in DA rats in vivo. CCL2-
triggered hyperalgesia was fully blocked in Wistar rats by
inhibitors of NADPH oxidase or ROS scavenging enzymes. In
summary, chemokine (CCL2)-mediated leukocyte recruitment is
linked to the induction of hyperalgesia via ROS generation in
recruited macrophages.
The role and function of chemokines in the generation of pain is
controversial [31]: the neutrophil-recruiting chemokine CXCL1
or CXCL2/3 evokes hyperalgesia [32] in some but not our studies
despite selective neutrophil recruitment [1,33]. In extension of our
previous studies, the monocyte-recruiting chemokine CCL2
(despite less leukocyte recruitment) elicited significant hyperalgesia
in Wistar rats. We found primarily inflammatory ED1+ (CD68+)
macrophages and some ED2+ resident macrophages (data not
shown) as seen in the skin [34]. In line with our findings, CCL2 is
an important gene up-regulated in various inflammatory and non-
inflammatory pain models in rats [35,36]. In neuropathic pain, the
pathogenic role of CCL2 is undisputed due to increased CCR2
expression in nociceptive neurons and CCR2-triggered hyperal-
Figure 4. Reconstitution of CCL2-induced hyperalgesia by adoptive transfer of macrophages derived from Wistar, but not from
Dark Agouti (DA) rats. (A) Mechanical nociceptive thresholds were quantified after i.pl. injection of 3 mg CCL2 with prior leukocyte depletion by
systemic injection of CTX (filled triangles), 3 mg CCL2 with prior systemic injection of solvent (cyclo-phosphamid (CTX) treatment (open circles), or
solvent of CCL2 without CTX treatment (filled circles). CTX injections were performed 3 d with 10 mg/kg and 1d 50 mg/kg before cell and/or CCL2
treatment. (B) Representative dot blots (x-axis: forward scatter (FSC) – cell size; y-axis: sideward scatter (SSC) – cell granularity) for leukocyte
subpopulations in peripheral blood of untreated (left) and CTX-treated Wistar rats (right) are shown by flow cytometry. Gates were set on beads (for
quantification), neutrophils, lymphocytes and monocytes. (C–F) Wistar and DA rats were leukocyte-depleted by i.p. injection with CTX followed by
i.pl. injection of different numbers of macrophages from either Wistar or DA rats, 30 min later, by i.pl. injection of 3 mg CCL2. Injection of 26106
macrophages without concomitant injection of CCL2 served as a negative control. (C) Wistar rats reconstituted with cells from Wistar rats. I.p.
injections of solvent only served as a negative control for CTX treatment (open triangles) with the same injection pattern. (D) Wistar rats reconstituted
with cells from DA rats. (E) DA rats reconstituted with cells from Wistar rats. (F) DA rats reconstituted with cells from DA rats. (*p,0.05 compared to
time point 0 h, Two Way RM ANOVA, Student-Newman-Keuls, n = 6). Data are presented as means 6 SEM.
doi:10.1371/journal.pone.0063564.g004
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Figure 5. Establishment of CCL2-induced hyperalgesia following restoration of defective ROS generation in Dark Agouti (DA) rats.
Peritoneal macrophages from Wistar and DA rats were isolated and treated for 1 h with 0.2 mg CCL2 or solvent control. ROS production was
quantified by flow cytometry using the phagoburst assay. Representative histograms are shown for Wistar rats (A) and DA rats (B) with solvent (grey),
CCL2 (black line) or positive assay control PMA (dotted line). (C) Results were analyzed statistically (n = 6/group, CCL2 i.pl. (white bars) or solvent
(black bars), *p,0.05, t-test). (D) Wistar and DA rats were i.pl. injected with CCL2 i.pl. (lower panel) or solvent (upper panels) for 3 h, subcutaneous
paw tissue was representative immunohistochemistry is shown for HNE (red), ED1+ macrophages (green) and merge of both together with nuclei
(DAPI-blue). (E) Wistar and DA rats were i.pl. injected with CCL2 i.pl. (white bars) or solvent (black bars) for 3 h, subcutaneous paw tissue was
prepared and HNE adducts were quantified by ELISA (n = 6/group, *p,0.05, t-test). (F) DA rats were s.c. injected with phytol for 5 days. Mechanical
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gesia by neuronal excitation [6]. In contrast, the molecular link
between the chemokine CCL2 and hyperalgesia in the absence of
neuropathy is more controversial. We hypothesized that ROS
generation could be this molecular link.
To further address the role of ROS generation in CCL2-
induced hyperalgesia, we performed experiments in DA rats. DA
rats are widely used in arthritis research because of their enhanced
susceptibility to arthritis [26] compared to Wistar rats [19] due to
defect in oxidative burst in macrophages in response to CCL2 or
other stimuli, which was demonstrated here and by others [18]. In
our study, DA rats generated comparable mechanical but less
thermal hyperalgesia to CFA-induced inflammation compared to
Wistar rats. No significant difference in the response to capsaicin
treatment in behavior tests or in whole cell recordings of cultured
DRG neurons was seen. However, because of the reduced thermal
hyperalgesia after CFA in DA rats, a subtle difference in TRPV1
nociceptive thresholds were quantified before and after i.pl. injection of CCL2 (0.3 mg – open circle, 1 mg – filled triangle, 3 mg – open triangle).
Control animals were treated 5 days with 0.9 % NaCl before i.pl. injection of 3 mg CCL2 (filled circle), (*p,0.05 versus time point 0 h, Two way RM
ANOVA, Student-Newman-Keuls, n = 6). Data are presented as means 6 SEM.
doi:10.1371/journal.pone.0063564.g005
Figure 6. Inhibition of CCL2-induced mechanical hyperalgesia by ROS scavenging in Wistar rats. Mechanical nociceptive thresholds
were quantified before and after (A) i.pl. injection of 1 mg apocynin with 3 mg CCL2 (filled circles) or 3 mg CCL2 alone and (B) i.pl. injection of 1 mg
apocynin (filled circles) or its solvent 0.9 % NaCl (open circles) in rats with 4 d CFA inflammation. (C–E) Mechanical nociceptive thresholds were
quantified before and after i.pl. injection of 3 mg CCL2 alone with the respective solvent (filled circle) or together with (C) SOD (3 U open circle, 30 U
filled triangle, 300 U open triangle), (D) catalase (2–5 U – open circle, 20–50 U – filled triangle, 200–500 U – open triangle), or (E) tempol i.p. (1.5 mg –
open circle, 7.5 mg – filled triangle, 15 mg – open triangle) (*p,0.05 versus time point 0 h, Two Way RM ANOVA, Student-Newman-Keuls, n = 6). Data
are presented as means 6 SEM.
doi:10.1371/journal.pone.0063564.g006
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responsiveness is possible which should be examined in further
studies. In a sciatic nerve ischemic injury model, DA rats develop
less pain-like responses and have a reduced area of intraneural
damage as well as higher nociceptive thresholds to heat and
mechanical stimulation [37]. In the sciatic nerve ischemic injury
model, ROS are supposed to play a role in the pathogenesis of the
nerve injury. Taken together, DA rats do not have a general defect
in nociceptive function but they are less responsive in selected pain
models which involve ROS or thermal inflammatory hyperalgesia.
To explore the reasons for the lack of CCL2-induced
hyperalgesia in DA rats, we found a reduced expression of
CCR2, reduced cell migration and a reduced ROS formation in
response to CCL2. Therefore, we propose that lack of CCL2-
induced hyperalgesia was due to reduced CCR2 expression and
consecutive defective migratory response and to a deficit in ROS
production. In vitro chemotaxis experiment effective agonist
concentration were observed ‘‘nM-pM’’ range while in vivo
behaviour experiment effective agonist concentration were seen
in ‘‘mM’’ range as observed before [2,23,28] possibly due to
dilution/degradation in the tissue. Interestingly, several other
groups demonstrated that in addition ROS generation is
important for chemokine induced chemotaxis and transendothelial
migration [38,39,40]. Oxidative burst in DA rats can be restored
by phytol, a pharmacologic inducer of oxidative burst[26]. Phytol
as a side chain of vitamin E is described as an NADPH-oxidase-
activating substance that ameliorates the arthritis in DA rats by
stimulating ROS production [26,41]. To sum up, several factors
contribute to the lack of CCL2-induced hyperalgesia in DA rats.
Previous studies have indicated that ROS play a major role in
the generation of pain. ROS have been implicated in neuropathic
pain and significantly contribute to central sensitization
[12,42,43]. Peripheral ROS generation, e.g. hydrogen peroxide,
or downstream products like HNE have also been shown to be
involved in the pathophysiology of pain via TRPA1 [44] and
TRPV1 [16]. Treatment with antioxidants reduces inflammation-
induced mechanical and thermal pain thresholds [11]. In our
study intraplantar CCL2 injection resulted in increased levels of
HNE in macrophages in Wistar rats. More importantly, blockage
of ROS formation using an NAPDH oxidase inhibitor apocynin,
or enhancement of ROS degradation using SOD, catalase or
tempol completely inhibited the CCL2-triggered hyperalgesia in
Wistar rats. On the contrary, in later stages of CFA inflammation
the NAPDH oxidase inhibitor apocynin could not reverse the
hyperalgesia in line with reduced CFA-elicited thermal hyperal-
gesia in DA rats. Summarized, CCL2-induced hyperalgesia is
critically dependent on ROS. This is in line with other studies
pointing to a pathogenic role of ROS in several models of pain.
In conclusion, CCL2 generates less thermal and mechanical
pain in DA compared to Wistar rats due to a lack p47phox, a
member of the NADPH oxidase complex, and a defect in CCR2
expression in macrophages. The monocyte/macrophage attract-
ing chemokine CCL2 directly triggered ROS via NADPH
oxidase. This was causally linked to the development of
hyperalgesia. In summary, we described ROS as the molecular
link between monocyte chemotaxis and inflammatory pain. A
better understanding of the molecular mechanisms of leukocyte
recruitment, activation and sensitization of nociceptors could
potentially provide new therapeutic approaches for the treatment
of inflammatory pain. This could be useful for both patients with
postoperative pain and for those with inflammatory rheumatic
diseases (e.g. rheumatoid arthritis).
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